AXQ Capital LP Acquires New Position in UnitedHealth Group Incorporated $UNH

Key Points

• AXQ Capital LP initiated a new position in UnitedHealth Group during the fourth quarter, buying 8,886 shares worth about $2.93 million. The stake now represents 0.7% of AXQ’s portfolio and is its fourth-largest holding.
• Several other institutional investors also increased or opened positions in UNH, and institutional ownership stands at 87.86%. That suggests the stock remains widely held by large investors despite recent volatility.
• Analyst sentiment is mostly positive, with multiple firms raising price targets and the consensus rating sitting at “Moderate Buy” with a target price of $399.50. Separately, UnitedHealth reported better-than-expected quarterly EPS and revenue, though the company also faces added legal and regulatory scrutiny.

AXQ Capital LP bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 8,886 shares of the healthcare conglomerate's stock, valued at approximately $2,933,000. UnitedHealth Group accounts for 0.7% of AXQ Capital LP's investment portfolio, making the stock its 4th largest holding.

Several other large investors also recently made changes to their positions in the stock. Vantus Wealth LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $445,000. Spinnaker Trust increased its position in UnitedHealth Group by 1.6% during the 4th quarter. Spinnaker Trust now owns 26,898 shares of the healthcare conglomerate's stock worth $8,879,000 after purchasing an additional 413 shares in the last quarter. One Capital Management LLC increased its position in UnitedHealth Group by 3.3% in the 4th quarter. One Capital Management LLC now owns 4,410 shares of the healthcare conglomerate's stock valued at $1,456,000 after acquiring an additional 142 shares during the period. BNP Paribas increased its position in shares of UnitedHealth Group by 65.1% during the fourth quarter. BNP Paribas now owns 31,952 shares of the healthcare conglomerate's stock worth $10,546,000 after buying an additional 12,601 shares during the period. Finally, Cercano Management LLC increased its position in shares of UnitedHealth Group by 18.7% during the fourth quarter. Cercano Management LLC now owns 90,927 shares of the healthcare conglomerate's stock worth $30,016,000 after buying an additional 14,312 shares during the period. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.28% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on UNH shares. Robert W. Baird increased their target price on shares of UnitedHealth Group from $278.00 to $287.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 22nd. HC Wainwright set a $492.00 price objective on shares of UnitedHealth Group in a report on Wednesday, May 27th. Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 22nd. Raymond James Financial upgraded shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 target price for the company in a research note on Wednesday, April 1st. Finally, Leerink Partners raised their price objective on shares of UnitedHealth Group from $345.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $399.50.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Truist raised its price target on UnitedHealth Group (UNH) from $395 to $440 and kept a buy rating, reinforcing Wall Street’s confidence in the stock’s upside. Benzinga report on Truist price target increase
• Positive Sentiment: UnitedHealth said it will eliminate nearly two-thirds of pediatric prior authorizations by year-end, a move that could reduce paperwork, speed care access, and improve provider relations. Can UnitedHealth's Pediatric Authorization Cuts Ease Care Delays?
• Positive Sentiment: Several recent commentary pieces highlighted UNH as a durable long-term cash-flow generator, which may be supporting investor sentiment around its healthcare scale and recurring demand. 247WallSt article
• Neutral Sentiment: Market commentary and social-media trading chatter showed continued interest in UNH, with traders pointing to support around the mid-$300s and upside targets near $400-$420, but this is more technical sentiment than a fundamental catalyst. Quiver Quantitative discussion summary
• Negative Sentiment: Massachusetts filed a lawsuit accusing UnitedHealth of inflating Medicaid patient risk scores to secure higher payments, adding legal, reputational, and reimbursement risk for the company. UnitedHealth Lawsuit Raises Fresh Questions On Medicaid Revenue And Investor Risk
• Negative Sentiment: Separate reporting on allegations tied to UnitedHealthcare’s Medicare Advantage advertising practices keeps regulatory scrutiny in focus, which can weigh on investor confidence. GlobeNewswire article

UnitedHealth Group Price Performance

UNH opened at $380.03 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $404.15. The stock has a market capitalization of $345.12 billion, a P/E ratio of 28.70, a P/E/G ratio of 1.64 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The company's 50-day simple moving average is $338.84 and its two-hundred day simple moving average is $321.92.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same quarter in the prior year, the firm earned $7.20 EPS. The business's revenue for the quarter was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 18.29 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.